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ABSTRACT 
 
 
Eman Hefni: Epigenetics and Transcriptional Dynamin in Periodontal Disease  
(Under the direction of Silvana Barros) 
 	
Objectives: Several studies have shown the involvement of epigenetics with periodontal 
disease.  Since functional dissociation of Paracellular permeability is expected during bacterial 
infection, we hypothesize that the methylation of host oral epithelial DNA represents an 
important element in the disruption of barrier function and pathogenesis of periodontal diseases. 
With this In vitro study, we aimed to assess whether there is altered epithelial permeability 
measuring trans epithelial resistance after Porphyromonas gingivalis (P. gingivalis), 
Campylobacter rectus (C. rectus) and Fusobacterium nucleatum (F. nucleatum) infection. 
Plakophilin2 (PKP2) methylation status and expression levels were also investigated. In 
addition, investigate the potential effects of DNA methyltransferase (DNMT) inhibitors on 
epithelial barrier function in response to infection with periodontal pathogen in human gingival 
epithelial cells.  
Methods: Primary human gingival epithelial cells (HGEPs) were stimulated with P. 
gingivalis, strain, C. rectus and F. nucleatum (MOI 50) either in the presence or absence of 
DNMT inhibitors (10 µM of RG108 or EGCG). CellTiter-Blue® Cell Viability Assay (Promega) 
was used to determine an optimum cell density and maximum inhibitor concentration at which 
cell viability is maintained. Transepithelial electrical resistance (TER) at various time points 
were performed using an EVOM® electrical resistance system. DNA methylation was quantified 
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by PCR using EpiTect Methyl II PCR Primer Assays for PKP2. Immunofluorescence 
analysis was performed using PKP2 antibody and analysis performed using Zeiss710 confocal 
microscope. 
 Results: Exposure of HGEPs to P. gingivalis resulted in decreased TER (P=<0.001) 
associated with increased cell permeability. Methylation assays showed increased methylation 
levels of the PKP2 in comparison to non-infected controls (P=<0.001) and an associated PKP2 
down-regulation (P=<0.005). For infected cells treated with DNMT inhibitors, PKP2 mRNA 
expression was increased (P=<0.001) and TER values similar to non-infected cells.  
Comparatively, immunofluorescent staining of the PKP2 protein showed reduced protein 
expression in infected cells not treated with DNMT inhibitors.  
Conclusion: DNA methylation levels of PKP2 can affect epithelial barrier function 
potentially conferring increased susceptibility to infection. DNMT inhibitors can affect cell 
adhesion dissociation in response to infection minimizing the disturbance to the barrier function. 
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CHAPTER1: LITERATURE REVIEW 	
I.1 Epigenetic, DNA Methylation – An Overview  
The term “epigenetics” was first used by Conrad H. Waddington (1942), who defined it 
as “the branch of biology that studies the causal interaction between genes and their product, 
which bring the phenotype into being” (Barros S.P & Offenbacher S, 2009; Goldberg A.D, Allis 
C.D, & Bernstein E, 2007; Sato P.Y et al., 2009). However, the definition has gradually changed 
over the following years, and epigenetics is known today as “the study of changes in gene 
function that are mitotically and/or meiotically heritable and that do not entail a change in DNA 
sequence”(Wu C.T & Morris J.R, 2001). Epigenetics modification lead to events which 
chemically modify certain DNA regions, leading to alteration of the chromatin and ultimately 
silencing or activation of a gene (Barros S.P & Offenbacher S, 2009; Gomez R.S, Dutra W.O, & 
Moreira P.R, 2009; Larsson L, Castilho R.M, & Giannobile W.V, 2015). Epigenetics are 
influenced by age, environmental factors, such as smoking and diet, and microbial exposures 
(Barros S.P & Offenbacher S, 2014). Any disruption of the balance of epigenetic mechanism can 
cause several major pathologies, including cancer, syndromes involving chromosomal 
instabilities, and mental retardation (Table 1) (Egger G, Liang G, Aparicio A, & Jones PA, 
2004). 
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Table 1.1 Epigenetic disease, the table is adopted from (Egger G et al., 2004) 
 
Various important epigenetic mechanisms include : DNA methylation, histone 
modifications ( methylation , acetylation , deacetylation) and non-coding RNA (Barros S.P & 
Offenbacher S, 2009; Egger G et al., 2004; Goldberg A.D et al., 2007; Lod, Johansson, 
Abrahamsson, & Larsson, 2014).  
DNA methylation is associated with gene silencing and is the most studied of the 
epigenetic processes, especially in the field of cancer research (Barros S.P & Offenbacher S, 
2009) (Goldberg A.D et al., 2007; Subramaniam D, Thombre R, Dhar A, & Anant S, 2014). 
DNA methylation occurs when a methyl group binds to a cytosine residue within the cytosine-
guanine dinucleotide (CpG) regions (Barros S.P & Offenbacher S, 2009; Larsson L et al., 2015) . 
Cytosines in CpA, CpC, and CpT dinucleotides can also be methylated, but less frequently 
(Rakyan, Down, Balding, & Beck, 2011). Methylated CpG regions interfere with the access of 
transcription factors to the promoter region, thereby silencing the gene. The process of DNA 
methylation is catalyzed by a family of DNA methyltransferases (DNMT1, DNMT2, and 
DNMT3). DNMT1 maintain DNA methylation during cell division, it copies DNA methylation 
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marks from the original to the nascent strand during DNA replication (Tang M, Xu W, Wang Q, 
Xiao W, & Xu R, 2009). DNMT2 catalyzes methylation of small RNA molecules and has some 
residual de novo DNA methyltransferase activity. The DNMT3 family has three members: 
DNMT3A, DNMT3B, and DNMT3L. DNMT3A and DNMT3B are responsible for de novo 
methyltransferases that methylate DNA without a template. DNMT3L lacks DNA 
methyltransferase activity but it enhances DNMT3A and DNMT3B activity (Lee & Pausova, 
2013). 
	
Figure 0.1 DNA methylation. (Adopted from (Larsson L et al., 2015) 
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DNA methylation is important for normal development and is associated with a number 
of key processes including genomic imprinting, X-chromosome inactivation, aging and 
carcinogenesis. Longitudinal Twin Study showed that there was divergence in DNA methylation 
patterns due to environmental rather than genetic influences (Wong C.Y et al., 2010). Another 
study showed loss of DNA methylation during aging (Gonzalo, 2010). Also, DNA methylation 
has been implicated in the development and progression of cancer mainly through 
hypermethylation of tumor suppressor genes and hypomethylation of oncogenes (Allis C.D & 
Jenuwein T, 2016). 
Since many human diseases have an epigenetic etiology this has encourage the 
development of a new therapy “Epigenetic therapy”. Many agent have been discovered to alter 
the DNA methylation and Histone modification and there are currently being tested in clinical 
trial. 
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Table 1.2 Epigenetic drugs, the table is adopted from (Egger G et al., 2004). 
 
The Epigenetic drug used to target DNA methylation is DNA Methyltransferase 
Inhibitor: 5-azacytidine (5-aza-CR), 5-aza-2V-deoxycytidine (5-aza-CdR), zebularine, procaine, 
(-) epigallocatechin-3-gallate (EGCG), and RG108 (Stresemann C, Brueckner B, Musch T, 
Stopper H, & Lyko F, 2006).  
Although DNA methylation has been identified as important components in various 
physiological and pathological processes, its role in periodontal pathogenesis healing has not yet 
fully investigated. 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I.2 DNA Methylation and Its Effect on the Periodontium  
Epigenetic events such as DNA methylation effect gene expression through selective 
activation or inactivation of genes. DNA methylation induce changes in immune mechanisms, 
cytokine profile, and thereby contribute to the pathogenesis of inflammatory diseases. 
Periodontitis is a multifactorial disease characterized by inflammation and destruction of the 
tooth supporting structures (Socransky SS, 1998). Periodontal diseases are caused by microbial 
biofilms. In classical studies, the increase in numbers and proportions of the “red complex” 
species (Porphyromonas gingivalis, Treponema denticola and Tannerella forsythia) in 
subgingival biofilms has been highly associated with the presence of periodontitis. Even though 
periodontitis has a microbial etiology, its progression can be influenced by other factors: 
systemic diseases, environmental factors, and genetic factors (Kornman K.S, 2008). 
It was recognized that pathogens in the oral mucosa may cause epigenetic changes in the 
host. In patients with squamous cell carcinoma of the head and neck region, bacteria were shown 
to be associated with methylation of the Multi-Drug Resistance Gene 1 (MDR1) (Bebek G et al., 
2012). Infection with C.rectus in pregnant mice induced hypermethylation of the murine placenta 
Igf2 which would affect the development of the newborn (Bobetsis Y.A et al., 2007). Persistent 
periodontal inflammation can also cause DNA methylation, which inactivates suppressors of 
cytokine signaling, resulting in exaggerated cytokine production. This lack of suppression 
renders an individual susceptible the development of a proinflammatory state, increasing the risk 
for periodontitis (Gomez R.S et al., 2009).  
Several studies have investigated the DNA methylation of inflammatory cytokines in 
chronic periodontitis. In vitro study showed that DNA methylation differentially affects gingival 
cytokine secretion (IL1a, IL6, TNFa, CXCL1) from epithelial cell in response to P. gingivalis or 
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F. nucleatum (Drury J.L & Chung W.O, 2015). Analysis of the methylation level of IL-6 in the 
gingival biopsy of periodontitis patient was similar to the control (Stefani F.A et al., 2013). In 
contrast, peripheral blood sample from periodontitis patient and rheumatoid arthritis showed 
lower methylation level of IL-6 compared to the control (Ishida K et al., 2012). Interestingly, a 
group reported that higher frequency of hypomethylation of IL8 promoter region was identified 
in oral epithelial cells from chronic periodontitis patients (Oliveira N.F et al., 2009). Regarding 
TNF-a, gingival biopsy from periodontitis patient showed higher level of DNA methylation at 
two CpG sites in the TNF-a promotor region compared to the healthy patient. The mRNA 
expression of TNF-a increase after treatment with 5-aza (Zhang S et al., 2013). Two studies 
have been investigated the methylation level of interferon (INF- g). (Zhang et al., 2010) found an 
increase transcription level of interferon INF- g and lower DNA methylation in periodontitis 
patient compared to healthy patient. On the other hand, (Viana M.B et al., 2011) found no 
different in the methylation status of  INF- g and IL10 between gingival biopsy of healthy and 
periodontitis patient. Larsson L et al,  (Larsson L, Thorbert Mros S, Rymo L, & Berglundh T, 
2012) reported three CpG sites in the distal IL-10 promotor region were methylated in both 
gingival biopsy and peripheral blood sample in periodontitis patient. Also, (Barros S.P & 
Offenbacher S, 2014) analysis several thousand gene using microarray and found different in 
DNA methylation level between healthy and inflamed gingiva.  
In addition to the methylation level of inflammatory cytokines another gene related to the 
inflammation have been studies in the periodontitis. The DNA methylation status of Toll – like 
receptor 2 (TLR2) and TLR4 was studies in gingival biopsy (De Oliveira N.F et al., 2011). TLR2 
was methylated and unmethylated in most of the sample. While TLR4 was unmethylated in most 
sample in all group. Another study report TLR2 methylation in periodontitis group (de Faria 
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Amormino S. A et al., 2013). There was an increase in the DNA methylation pattern of E 
cadherin and cyclooxygenase2 (COX-2) for periodontitis and cancer patients (Loo W.T, Jin L, 
Cheung M.N, Wang M, & Chow L.W, 2010). In addition to that chronic periodontal disease is 
associated with increased DNA methylation of the prostaglandin endoperoxide synthase 2 
(PTGS2) promoter, the gene coding for cyclooxygenase (COX-2), resulting in lower level of 
COX-2 expression (Zhang S et al., 2010). In the periodontal ligament of aged individuals, the 
decreased expression of collagen α1 gene is associated with DNA hypermethylation at most CpG 
sites in the proximal and distal regions of the promoter (Ohi T, Uehara Y, Takatsu M, Watanabe 
M, & Ono T, 2006).  
However, relatively little is known about the role epigenetics plays in the progression and 
development of periodontal disease. 
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I.3 Epithelial Barrier function 
The epithelium of the periodontal pocket or gingival sulcus is the first line of defense 
against bacterial invasion of periodontal pathogens. Disruptions of gingival epithelial cell barrier 
allow bacteria and bacterial products to enter into the underlying tissues, activate immune 
responses and cause bone resorption. 
The integrity of epithelial tissue is maintained by several cell-to-cell adhesions and 
junctions, including tight junctions, adherent junctions, gap junctions and desmosomal junctions 
(Groeger S.E & Meyle J, 2015). Desmosomal and adherens junction act as anchoring adhesion 
structure in various tissues including oral epithelial (Nagafuchi A, 2001). 
Adherent junction regulates the activity of the entire junctional complex. It is a cell 
junction where anchoring protein (cadherin and integrins) attached to actin filaments. Cadherin is 
calcium dependent adhesion molecule directly bind to beta-catenin or plakoglobin, which in turn 
bind to the α catenin and at the end bind to actin. These adherent junctions are important for 
epithelial morphogenesis and formation of mature of cell-cell contacts. 
Desmosomal junctions are cell-cell adhesive structures that maintain the structural 
integrity of tissue. Usually it is abundant in tissues that experience mechanical stress such as the 
epithelium and heart. The components of the desmosome are Desmocollin (Dsc) and desmoglein 
(Dsg). The transmembrane cadherins bind a group of cytoplasmic proteins termed desmosomal 
plaque proteins that include plakoglobins (PG), desmoplakins (DP), and plakophilins (PKP). The 
plaque proteins in turn recruit the intermediate filament cytoskeleton (Keratin) to the 
transmembrane desmosomal cadherins and assemble the electron dense desmosomal plaque 
(Stokes D.L, 2007). 
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Several studies report the effect of periodontal pathogen on the expression of epithelial 
junctions. Dickinson et al showed that the anaerobic periodontal pathogen P. gingivalis was able 
to invade the oral epithelium and contaminated epithelial cells, while actinomycetemcomitans 
and F. nucleatum remained extracellularly. Also, when they measured the transepithelial 
electrical resistance none of the bacterial species disrupted barrier function (Dickinson B.C et al., 
2011). Moreover, P. gingivalis is able to invade the deeper structures of connective tissues and 
decrease the transepithelial resistance through decreases in the amounts of immunoreactive 
occludin, E-cadherin, and 1-integrin which were related to a disruption of cell-cell junctions in 
MDCK cells (S. V. Katz J, Wu J.H, Michalek S.M, Balkovetzd D.F, 2000). Groeger S et al. have 
shown a distinct effect on epithelial barrier after infection with P. gingivalis due to the virulence 
factor gingipain (Groeger S, Doman E, Chakraborty T, & Meyle J, 2010). In this study, we will 
focus mainly on E-cadherin and Plakophilin expression after bacteria stimulation (figure 1.2).  
	 10	
	
Figure 0.2 Epithelial cell adherent and desmosomal junction (adopted from Goossens S et al 
(2007) 
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I.4 E-cadherin 
E-cadherin (CDH1) is a calcium-dependent cell adhesion molecule (Van Roy F & Berx 
G, 2008). It is considered Type I classic cadherin that mediate a strong cell-cell adhesion 
(Halbleib J.M & Nelson W.J, 2006). The E-cadherin molecule has extracellular, transmembrane 
and intracellular domains. The cell–cell adhesion function resides in the extracellular domain. 
The intracellular domain is linked to the actin cytoskeleton via a, b and p120 catenins (Canas-
Marques & Schnitt, 2016). Decreased E-cadherin gene transcription results in a loss of cell–cell 
adhesion and increased cell migration (Thiery, 2002). B-catenin protein has an important role in 
cell adhesion, it also functions in the Wnt signal transduction pathway (Miller & Moon, 1996). In 
spinous layers of the oral gingival epithelium and sulcular epithelium, E-cadherin act as the main 
transmembranous molecule of adherens junctions (Hatakeyama S et al., 2006). E-cadherin work 
as a tumor suppressor gene (Christofori G & Semb H, 1999). 
E-cadherin silencing or reduction of expression has been associated with different 
mechanisms: germ line mutations (Sarrio et al., 2003), single nucleotide polymorphisms (Li, 
Pan, Guo, & Li, 2014), frame shift and splice site mutations (Droufakou S, 2001), gene deletion, 
and epigenetic events such as DNA Methylation (Grady W et al., 2000).  
Mutations E-cadherin (CDH1) are associated with gastric, breast, and colorectal, thyroid, 
ovarian cancers (Berx G, Becker KF, Höfler H, & FV, 1998; Canas-Marques & Schnitt, 2016; 
Pharoah, Guilford, & Caldas, 2001). DNA methylation and repression of promoter activity 
directly regulate E-cadherin transcription. Methylation of the E-cadherin promoter is associated 
with reduced E-cadherin expression, and with disease progression and metastasis. 
E-cadherin degradation via an intercellular pathway happen when C. albicans invades 
mucosal tissues (Villar C.C, Kashleva H, Nobile C.J, Mitchell A.P, & Dongari-Bagtzoglou A, 
	 12	
2007). Recent study by Abe-Yutori showed decrease in E-cadherin expression in human gingival 
epithelial cells by P. gingivalis - lipopolysaccharide and they were able to show that H2O2, a 
major ROS, induced a decrease in E-cadherin expression (Abe-Yutori, Chikazawa, Shibasaki, & 
Murakami, 2016). Another study showed that P. gingivalis bacterial protease are capable of 
degrading epithelial junction transmembrane proteins (occludin, E-cadherin, and 1-integrin) in 
Madin-Darby canine kidney (MDCK) cells (Katz, Sambandam, Wu, Michalek, & Balkovetz, 
2000). Rubinstein et al. (2013) show that F. nucleatum, Promotes colorectal carcinogenesis via 
binding of the adhesion molecule, FadA, to E-cadherin, results in downstream activation of NF-
Kb (Rubinstein et al., 2013). 
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I.5 PKP2 
The Plakophilins (PKP) proteins are a family of desmosomal plaque proteins that link 
cadherin to the keratin. They are members of the p120ctn family of armadillo related proteins 
(Hatzfeld M, 2007). Plakophilins have been shown to be important for desmosome formation, 
clustering, and maturation through interactions with the desmosomal cadherins, desmoplakin, 
intermediate filaments, and perhaps actin. Any disturbance of plakophilins functions lead to 
inherited diseases and cancer pathogenesis (Bass-Zubek A.E, Godsel L.M, Delmar M, & Green 
K.J, 2009). Plakophilins are located at the membrane, in the cytoplasm, and in the nucleus 
(Koetsier J.L, Amargo E.V, Todorovic V, Green K.J, & Godsel L.M, 2014; Schmidt A et al., 
1997). They consist of 4 closely related gene products, PKP 1–4, which contain arm-repeat 
(armadillo) domains and located at the membrane, in the cytoplasm, and in the nucleus of in all 
cell types with desmosomal junctions (Koetsier J.L et al., 2014; Schmidt A et al., 1997). PKP1 
regulates cell migration and mediates increases in desmosomal protein content. PKP2 plays an 
important role in desmosome assembly and  mainly expressed in the basal cell layer (Bass-Zubek 
A.E et al., 2009; Hatzfeld M, 2007). PKP3 is essential for desmosome dependent adhesion and 
signaling pathways. PKP4 is a component of desmosomal adhesion plaques that regulates 
junctional plaque organization and cadherin function (Takahashi H et al., 2012). Up to date no 
data are available if these proteins are integrated into any signaling pathways as shown for other 
junctional plaque proteins. (Schwarz J et al., 2006) 
Mutations in PKP2 cause a severe inherited heart disease arrhythmogenic right 
ventricular cardiomyopathy (ARVC) (Hall C, Li S, Li H, Creason V, & Wahl J.K, 2009; 
Trenkwalder T, Deisenhofer I, Hadamitzky M, Schunkert H, & Reinhard W, 2015). Studies 
showed that elevated PKP2 levels are associated with tumor progression of oropharyngeal 
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cancers (Papagerakis S, AH, Depondt J, Gehanno P, & Forest N, 2003), prostate, colorectal, 
pancreatic (Schwarz J et al., 2006) and invasive bladder cancer (Takahashi H et al., 2012) but 
tumor suppressive effects of PKP2 have not been reported for any cancer cells.  
PKP2 is considered a novel activator of the Epidermal Growth Factor Receptor (EGFR) 
signaling pathway and a potential new drug target for inhibiting tumor growth (Arimoto K et al., 
2014). PKP2 loss results in a loss of desmoplakin (DP) assembly competence and its failure to 
accumulate normally at borders (Bass-Zubek A.E et al., 2008). Recent study showed that loss of 
PKP2  lead to loss of desmoplakin (DP) which lead to promotes TGF-β1/p38 MAPK- dependent 
fibrotic gene expression in cardiomyocytes (Dubash A.D et al., 2016) 
One of the studies in our lab showed decrease in PKP2 in periodontitis patients. P. 
gingivalis specifically degrades PKP2 protein through cysteine proteases, not serine proteases, or 
intracellular proteasomal or lysosomal degradation pathways. Although in vitro stimulations of 
P. gingivalis increase the overall PKP2 DNA methylation level, periodontitis gingival biopsies 
do not display differential DNA methylation patterns compared to the healthy biopsies (Yu, 
2015). Furthermore, a recent gene wide association study showed a significant association 
between an SNP variant of PKP2 (rs6488099) that is located on chromosome 12 locus and 
periodontal disease (p=1.1x10-8|) (Figure 1.3) (Offenbacher S et al., 2016). From all of this data, 
further study is needed to understand the role of PKP2 in periodontal disease. In this study, we 
aim to investigate the effect of P. gingivalis and C. rectus and F. nucleatum on epithelial barrier 
function and if it is inducing epigenetic changes to the PKP2 – E cadherin. 
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Figure 0.3 Manhattan blot showing PKP2 SNP on chromosome #12 (adopted from (Offenbacher  
et al., 2016)
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CHAPTER II: EPIGENETIC AND TRANSCRIPTIONAL DYNAMIC IN PERIODONTAL 
DISEASE 	
II.1 INTRODUCTION  
 Epigenetics is known today as “the study of changes in gene function that are mitotically 
and/or meiotically heritable and that do not entail a change in DNA sequence”(Wu C.T & Morris 
J.R, 2001). Epigenetics modification lead to events which chemically modify certain DNA 
regions, leading to alteration of the chromatin and ultimately silencing or activation of a gene 
(Barros S.P & Offenbacher S, 2009; Gomez R.S et al., 2009; Larsson L et al., 2015). Epigenetics 
are influenced by age, environmental factors, such as smoking and diet, and microbial exposures 
(Barros S.P & Offenbacher S, 2014). Any disruption of the balance of epigenetic mechanism can 
cause several major pathologies, including cancer, syndromes involving chromosomal 
instabilities, and mental retardation (Table 1) (Egger G et al., 2004). Various important 
epigenetic mechanisms include : DNA methylation, histone modifications ( methylation , 
acetylation , deacetylation) and non-coding RNA (Barros S.P & Offenbacher S, 2009; Egger G et 
al., 2004; Goldberg A.D et al., 2007; Lod et al., 2014). DNA methylation is associated with gene 
silencing and is the most studied of the epigenetic processes, especially in the field of cancer 
research (Barros S.P & Offenbacher S, 2009) (Goldberg A.D et al., 2007; Subramaniam D et al., 
2014). DNA methylation induce changes in immune mechanisms, cytokine profile, and thereby 
contribute to the pathogenesis of inflammatory disease. Epigenetic changes unlike genetic 
changes, it can be reversed by pharmacological intervention such as 5-aza (DNMT inhibitor) 
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which is FDA approved for treatment of myelodysplastic syndrome (Kaminskas E, Farrell A.T, 
Wang YC, Sridhara R, & Pazdur R, 2005) 
 
Also, recently it has been recognized that periodontal pathogens in the oral mucosa may 
lead to epigenetic changes in the host tissues. In studies involving patients presenting with 
squamous cell carcinoma of the head and neck region, bacteria were shown to be associated with 
methylation of the Multi-Drug Resistance Gene 1 (MDR1) .Our group was the first to show in 
mouse model, that maternal infection with specific periodontal pathogen, C.rectus, could induce 
hypermethylation of Igf2 investigated in the murine placenta, with associated downregulation of 
the specific gene and fetal growth restriction, with potential   interference  in the development of 
the offspring (Bobetsis Y.A et al., 2007).  
Persistent periodontal inflammation can also cause DNA methylation, which inactivates 
suppressors of cytokine signaling, resulting in exaggerated cytokine production, this lack of 
suppression renders a susceptible individual the development of a proinflammatory state, 
increasing the risk for periodontitis (Gomez R.S et al., 2009). Several studies have investigated 
the DNA methylation of inflammatory cytokines and other genes related to the inflammation in 
chronic periodontitis such as hypermethylation of TNF-a (Zhang et al., 2010), TLR2 (de Faria 
Amormino S. A et al., 2013), E-Cadherin, COX-2 (Loo W.T, Jin L, Cheung M.N, Wang M, & 
Chow L.W, 2010), PTGS2 (Zhang S et al., 2010) in periodontitis patient. In vitro study showed 
that DNA methylation differentially affects gingival cytokine secretion (IL1a, IL6, TNFa, 
CXCL1) from epithelial cell in response to P. gingivalis or F. nucleatum (Drury J.L & Chung 
W.O, 2015). 
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However, the role that epigenetics plays in the progression and development of 
periodontal disease is still under investigation (Barros S.P & Offenbacher S, 2014) .  
The oral epithelium plays an important role in host defense against pathogens either by 
providing a physical barrier against bacterial challenge and invasion or activator of the innate 
immune responses. The integrity of epithelial tissue is maintained by several cell-to-cell 
junctions, including tight junctions, adherent junctions, gap junctions and desmosomal junctions. 
Furthermore, a recent gene wide association study showed a significant association between an 
SNP variant of PKP2 (rs6488099) that is located on chromosome 12 locus and periodontal 
disease (p=1.1x10-8) (Offenbacher S et al., 2016).  
The Plakophilins (PKP) proteins are a family of desmosomal plaque proteins that link 
cadherin to the keratin. They are members of the p120ctn family of armadillo related proteins 
(Hatzfeld M, 2007). Plakophilins have been shown to be important for desmosome formation, 
clustering, and maturation through interactions with the desmosomal cadherins, desmoplakin, 
intermediate filaments, and perhaps actin. Any disturbance of plakophilins functions lead to 
inherited diseases and cancer pathogenesis (Bass-Zubek A.E et al., 2009). Plakophilins are 
located at the membrane, in the cytoplasm, and in the nucleus of in all cell types with 
desmosomal junctions (Koetsier J.L et al., 2014; Schmidt A et al., 1997). They consist of 4 
closely related gene products, PKP 1–4, which contain arm-repeat (armadillo) domains and are 
localized to nuclei and cell desmosomes. PKP1 regulates cell migration and mediates increases 
in desmosomal protein content. PKP2 plays an important role in desmosome assembly and 
mainly expressed in the basal cell layer (Bass-Zubek A.E et al., 2009; Hatzfeld M, 2007). 
Mutations in PKP2 cause a severe inherited heart disease arrhythmogenic right ventricular 
cardiomyopathy (ARVC) (Hall C et al., 2009; Trenkwalder T et al., 2015). Studies showed that 
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elevated PKP2 levels are associated with tumor progression of oropharyngeal cancer 
(Papagerakis S et al., 2003), colorectal, pancreatic (Schwarz J et al., 2006) and invasive bladder 
cancers (Takahashi H et al., 2012), but tumor suppressive effects of PKP2 have not been 
discussed for any cancer cells. Up to date no data are available if these proteins are integrated 
into any signaling pathway as shown for other junctional plaque proteins. (Schwarz J et al., 
2006). 
In this study, we aim to investigate the effect of Periodontal pathogen on oral epithelial 
barrier function and if it is inducing epigenetic changes to the PKP2 or E-cadherin and what is 
the potential effects of DNA methyltransferase (DNMT) inhibitors on epithelial barrier function. 
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II.2 AIMS 
I. To determine whether infection of human gingival epithelial (HGE) cells with P. gingivalis, 
C. rectus and F. nucleatum are associated with altered epithelial barrier permeability.  
II. To determine the methylation status of PKP2 and E-cadherin after infection of HGE cell with 
P. gingivalis, C. rectus and F. nucleatum. 
III. Investigate the potential effects of DNA methyltransferase (DNMT-1) inhibitors on epithelial 
barrier function in response to infection with periodontal pathogen in human gingival 
epithelial cells. 
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II.3 HYPOTHESES 
It is hypothesized that infection of HGE cells with periodontal pathogen are able to 
induce epigenetic changes which, alter the epithelial barrier function and if there is epigenetic 
change we can prevent it using targeted epigenetic therapy.  
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II.4 MATERIALS AND METHODS: 
II.4.1 Cell and Bacterial Culture  
Human gingival epithelial cells (HGE) were purchased from CellnTec and maintained 
according to the manufacturer’s instructions. All cultures would be maintained in a 5% CO2, 
100% humidity, 37°C incubator and used between passages 3 and 6.  
Porphyromonas gingivalis (P. gingivalis) A7436 and Fusobacterium nucleatum (F. nucleatum) 
25586 were cultured anaerobically at 37ºC in Wilkins-Chalgren anaerobe broth medium (Thermo 
Scientific) for 3-4 days. Cell number measured via the optical density. When the optical density 
reaches 0.5, the concentration of P. gingivalis or F. nucleatum is equal to 109 CFU/ml.  
Campylobacter rectus (C. rectus) strain 314 was cultured anaerobically in Enriched Tryptic Soy 
Agar (ETSA) plate (Anaerobic System) for 4-5 days. When the optical density reaches 1.0, the 
concentration of C. rectus is equal to 109 CFU/ml. Upon the In vitro stimulation, bacteria were 
pelleted at a speed of 6000g for 15mins, washed with 1X PBS twice, and reconstituted in the cell 
culture medium. For the heat kill P. gingivalis it was inactivated for 30 minutes at 60°C before 
infection of HGE. 
 
II.4.2 Cell viability  
Human gingival epithelial cells (HGE) were plated in 96-well plates at densities ranging 
from 10,000 to 30,000 cells cm-2. The cells were allowed to attach for 24h, and then either 
RG108 (N-Phthalyl-L-tryptophan) was added at 1, 5, 10,15 µM or ECGC (Epigallocatechin 
gallate) was added at 10, 25, 50 µM for 24h. CellTiter-Blue® Cell Viability Assay (Promega) 
was used to determine an optimum cell density and maximum inhibitor concentration at which 
cell viability is maintained.  
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II.4.3 Transepithelial electrical resistance (TER)  
HGE were seeded in a 12mm Trans well with 0.4um Pore Polyester Membrane Insert 
(Costar). After 24 hours, the cells were attached to the membrane surface of the insert, which is 
oriented so that and the apical part of the cell is oriented upwards and the basal parts of the cells 
are towards the membrane surface of the insert. Transepithelial electrical resistance (TER) was 
measured using EVOM2 Epithelial Voltammeter at different time point: 2h, 4h, 6h, 8h and 24h. 
Background resistance from cell free membranes will be subtracted from initial resistance 
values.  
 
 II.4.4 RNA Isolation and Quantitative Real-Time Reverse Transcription PCR  
RNA was isolated from HGE cells using RNeasy Mini kit (Qiagen, Valencia, CA). The 
RNA was quantified using the Nano Drop (Thermo Scientific, Wilmington, DE). For each 
sample, a volume of 300 ng of RNA was used to generate complementary DNA (cDNA) through 
reverse transcription reactions using the using the SuperScript® VILO™ cDNA Synthesis Kit 
(Invitrogen TM, Life Technologies TM, Grand Island, NY). Quantitative real-time PCR (qRT-
PCR) was performed using 2µL of synthesized cDNA, 7.5µL of Taqman® Universal PCR 
Master Mix, .75µL of Taqman® Gene Expression Assay Mix for PKP2 or CDH1 gene and 
5.5µL of ddH2O in a 7000 Sequence Detection System (ABI Prism, Applied Biosystems, 
Carlsbad, CA). mRNA expression level was normalized using GAPDH as a housekeeping gene.  
 
II.4.5 DNA Isolation, Selective Digestion and Quantitative Real-Time PCR  
Genomic DNA was isolated from HGE using a DNeasy Mini Kit (Qiagen, Valencia, 
CA). The DNA was quantified using the NanoDrop (Thermo Scientific, Wilmington, DE). 500 
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ng of genomic DNA isolated from HGE cells was digested using EpiTect Methyl II DNA 
Restriction Kit (Qiagen Cat# 335452). DNA was aliquot into four equal portions. Each portion 
was subjected to a different reaction: Mock digest (no digestion), methylation sensitive digest 
(digestion of unmethylated and partially methylated DNA only), methylation dependent digest 
(digestion of methylated DNA only), and double digest (digestion of both methylated and 
unmethylated DNA). DNA digestion was allowed to take place at 37°C for 6 hours to overnight. 
Following the digestion inactivate the enzymes at 65° C for 20 minutes. Digested DNA was then 
quantified by qPCR using EpiTect Methyl II PCR Primer Assay for Human PKP2 (CpG Island 
103034) and Human CDH1 (cadherin 1, type 1, E-cadherin) (CpG Island 105415). Quantitative 
Real time -PCR (qRT-PCR) was performed using 12.5µL of RT SYBR Green qPCR Master 
Mix, 1µL of PCR primer mix for PKP2 or CDH1 gene, 1µL of each digested DNA and 10.5µL 
of ddH2O in a 7000 Sequence Detection System (ABI Prism, Applied Biosystems, Carlsbad, 
CA). Data analysis was done using integrated Excel-based templates provided by the 
manufacturer, which provide gene methylation status as percentage unmethylated (UM) and 
percentage methylated (M) fraction of input DNA. Unmethylated (UM) represents the fraction of 
input genomic DNA non-methylated CpG sites in the amplified region of a gene. Methylated 
(M) represents the fraction of input genomic DNA containing two or more methylated CpG sites 
in the targeted region of a gene. A relative methylation fold change to controls can be 
reported. The promotor region of PKP2 gene was evaluated in present study (UniGene No: 
Hs.164384; NCBI ID: 5318). The location of CpG island is Chr12: 33049301 – 33050098 
(Figure II.1). The promotor region of E-cadherin gene was evaluated in present study (UniGene 
No: Hs.461086; NCBI ID: 999). The location of CpG island is: Chr16: 68770974 – 68772344 
(Figure II.2) 
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Figure 0.1 PKP2 (CpG Island 103034): Chr12: 33049301 – 33050098 
	
Figure 0.2CDH1 (CpG Island 105415): Chr16: 68770974 – 68772344 	
II.4.6 Immunofluorescence staining (IF)  
HGE cells will be seeded in 35mm glass culture dishes (MatTek). At the end of the 
stimulation, cells were fixed with 4% paraformaldehyde for 10 minutes, Permeablized with 0.1% 
Triton X-100 in PBS for 30 mins, and blocked with 1% BSA/PBS/0.1% Triton X-100 at RT for 
1h. Primary antibody Anti PKP2 (1:400 dilutions, Santa Cruz, sc-393711). 
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II.4.7 Statistical Analysis  
Changes of TER were tested using the ANCOVA. The one-way ANOVA test was 
applied for comparison in viability, mRNA expression and DNA methylation among various 
groups. The threshold for statistical significance was set at a p-value <0.005. All analyses were 
performed with SAS 9.2 (SAS Institute, Cary, NC, USA).  
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II.5 RESULTS: 
II.5.1 Effect of P. gingivalis, C. rectus and F. nucleatum infection on epithelial barrier function: 	
The permeability of the epithelial barrier is commonly assessed by measuring TER. It is a 
measure of the barrier to small ions (predominantly Na and Cl) in an experimentally applied 
electrical field in the bathing medium. Assessment of the TER after infection HGE cells with 
different periodontal pathogen provided information on the ability of this pathogen to alter the 
epithelial barrier function. Changes in TER after infection of HGE with P. gingivalis, C. rectus 
and F. nucleatum were seen (Figure II.3). At the first 2 hour, an acute drop of TER can be 
observed after apical infection of HGE with P. gingivalis and C. rectus and F. nucleatum but it 
was statistically significant with P. gingivalis (p-value <0.0001). Exposure of HGE to P. 
gingivalis decreased the TER in a time dependent manner and it was statistically significant over 
24 h (p-value <0.0001). For C. rectus and F. nucleatum It can be seen that after 2 h the system 
equilibrated but it did not go back 100% to the normal barrier function. These data indicate that 
P. gingivalis was able to invade HGE and disrupt the barrier function. 
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Figure 0.3 The adjusted mean TER of human gingival epithelial (HGE) after apically infected 
with P. gingivalis A7436, C. rectus 314 and F. nucleatum 25586 for 2h, 4h, 8h and 24h 
The results are expressed in mean of TER and standard deviations, the baseline TER of was 
adjusted to the control. 
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II.5.2 mRNA Expression of PKP2 and E-cadherin after infection with P. gingivalis, C. rectus 
and F. nucleatum infection: 	
The impact of P. gingivalis, C. rectus and F. nucleatum infection on mRNA expression 
of PKP2 and E-cadherin gene in HGE was evaluated. Infection duration for 24 h was tested. 
mRNA Expression of PKP2 in response to infection with live P. gingivalis show a statistically 
significant down-regulation (p-value <0.0001) (Figure II.4). While infection with C. rectus and 
F. nucleatum showed a slight down-regulation but it was not statistically significant.  The fold 
changes for the HGE infected with live P. gingivalis, heat killed P. gingivalis, C. rectus and F. 
nucleatum were 0.36±0.08, 0.74±0.14,0.89±0.2 and 0.67±0.06 respectively. Results suggest that 
decrease epithelial PKP2 mRNA is associated with live P. gingivalis. 
For E-cadherin, the mRNA Expression of PKP2 in response to infection with live P. gingivalis, 
and F. nucleatum shows no different compare to the control (p-value >0.05). On the other hand, 
Infection with heat kill P. gingivalis and C. rectus shows upregulation of E-cadherin but it only 
was significant for the heat kill P. gingivalis (p-value <0.005). 
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Figure 0.4 mRNA Level of PKP2 and E-cadherin after infection with live and heat kill P. 
gingivalis A7436, C. rectus 314 and F. nucleatum 25586 at MOI 50 for 24h 
 
II.5.3 Effect of P. gingivalis, C. rectus and F. nucleatum infection on PKP2 and E-cadherin 
Global DNA methylation  	
We want to check the role of the bacteria (P. gingivalis, C. rectus and F. nucleatum) in 
inducing epigenetic changes as DNA methylation. In HGE infected with live P. gingivalis there 
was a statistically significant increase in the hypermethylation level of the PKP2 promotor (p-
value<.0001) compared to the control non-infected HGE samples (Figure II.5). On the other 
hand, infection of HGE with C. rectus or F. nucleatum showed no increase in the methylation 
level of the PKP2. The percentages of hypermethylation in the control non-infected, HGE 
infected with live P. gingivalis and heat killed P. gingivalis, C. rectus and F. nucleatum were 
1.24± 0.01, 0.77±0.002, 16.32±0.01, 2.83± 0.002 and 0.9 ±.0003 respectively. For E- cadherin, 
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there was no increase in the methylation level after infection with P. gingivalis, C. rectus or F. 
nucleatum. The percentages of hypermethylation in the control non-infected, HGE infected with 
live P. gingivalis and heat killed P. gingivalis, C. rectus and F. nucleatum were 0.09± 0.006, 
2.00±0.005, 2.1±0.006, 0.9± 0.001 and 3.7 ±.02 respectively. Results suggest that live P. 
gingivalis is able to cause a DNA methylation and effect gene expression of PKP2 which was 
confirm by mRNA expression of PKP2.  
 
	
Figure 0.5 Mean percentage of DNA hypermethylation for PKP2 / E-cadherin gene in response 
to infection with P.g A7436, C. rectus 314 and F. nucleatum 25586 at MOI 50 for 24h 
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II.5.4 DNMT-1 inhibitors concentration optimization  
Experimental optimization was completed to ensure cell viability and health (Figure II.6) 
shows the results of HGE exposure to a range of concentration of RG108 and EGCG for an 
optimal seeding density of 20 000 cells cm-2. The stars indicate the maximum inhibitor 
concentration in which viability was statistically significant affected compared to untreated 
cultures (p > 0.05). The arrow indicates the maximum inhibitor concentration used in all 
subsequent experiments, 10 µM for RG108 and EGCG. 
 
Figure 0.6 HGE viability following Inhibitor Treatment	
II.5.5 Effects of DNA Methylation Inhibitors on Epithelial barrier function  
HGE expression of PKP2 was assessed to determine if DNMT-1 inhibitors were affecting 
the methylation status on the responsiveness to HGE to bacterial challenges. We repeat the TER 
experiment after treatment with either RG108 or EGCG alone (Figure II.7). TER result showed 
improve in the TER of the pretreated HGE with DNMT-1 inhibitors compare to the HGE 
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infection with P. gingivalis (p-value <0.005). Also, the mRNA expression of PKP2 was 
significantly increase (p-value <0.001) when HGE were pretreated with DNMT-1 inhibitors then 
exposed to P. gingivalis (Figure II.8).  The fold changes for the HGE pretreated with RG108 or 
EGCG then exposed to live P. gingivalis were 2.17±0.14 and, 1.51±0.05 respectively. In addition 
to the increase in the PKP2 expression, pretreatment of HGE with DNMT-1 inhibitors followed 
by P. gingivalis stimulation result in statistical significant decrease in the methylation level of 
PKP2 compare to the HGE infected with live P. gingivalis. The percentage of hypermethylation 
for the HGE pretreated with RG108 or EGCG then exposed to P. gingivalis were reduce to 
1.5±0.001, 0.4±0.003 respectively (Figure II .9). These results suggest a protective effect of 
DNMT-1 inhibitors on the epithelial barrier function against P. gingivalis. 
	
Figure 0.7 Time response of TER of human gingival epithelial (HGE) after pretreat the HGE 
with RG108 or EGCG then exposed to P. gingivalis A7436 at MOI 50 for 2h, 4h, 8h and 24h 
The results are expressed in mean % and standard deviations, the baseline TER of was adjusted 
to the control. 
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Figure 0.8 mRNA Level of PKP2 after pretreat the HGE with RG108 or EGCG then exposed to 
P. gingivalis. 
	
Figure 0.9 Mean percentage of DNA hypermethylation for PKP2 after pretreated the HGE with 
RG108 or EGCG then exposed to P. gingivalis. 
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II.5.6 Immunofluorescence studies. 
Control non-infected HGE cells showed uniform staining for PKP2 (Figure II. 10) while 
HGE infected with P. gingivalis or F. nucleatum showed decrease in immunofluorescence 
labeling intensity. While, pretreatment with DNMT-1 inhibitors followed by P. gingivalis 
stimulation showed increase in immunofluorescence labeling intensity of PKP2. 
	
Figure 0.10 Immunofluorescent staining of PKP2 
 			
	 36	
II.6 DISCUSSION  
The Oral epithelium plays an important role in host defense against pathogens either by 
providing a barrier against bacterial challenge and invasion or activator of the innate immune 
responses. In the present study, we investigated the effects of the periodontal pathogen P. 
gingivalis on PKP2, which are important desmosomal protein involved in cell adhesion and in 
maintaining the integrity of the oral epithelium. Also, we want to check if the epithelial barrier 
function affected through PKP2 that may be under epigenetic control. Our approach involved 
treating HGE with known inhibitors of methylation and then exposing both treated and untreated 
cells P. gingivalis. Differences in response indicate the potential for epigenetic control. First, we 
measured the TER of HGE which we believe it would give us an estimation of the integrity of 
epithelial barrier function especially PKP2. Since Sato P.Y et al, showed that loss of Plakophilin-
2 expression result in decreased sodium current and slower conduction velocity in cultured 
cardiac myocytes (Sato P.Y et al., 2009) and the TER is a measure of the barrier to small ions 
(predominantly Na and Cl) in an experimentally applied electrical field in the bathing medium 
(Fanning A.S, Mitic L.L, & Anderson J.M, 1999). In the present study, we have shown a 
statistically significant decrease in the TER of HGE cells within 2 h after exposure to P. 
gingivalis. The 2h initial invasion time for P. gingivalis was consistent with previous study 
which report 90 min for P. gingivalis invasion (Chung W.O et al., 2001; Lamont RJ et al., 1995).  
The change in TER after infection with C. rectus and F. nucleatum was not significant. The 
result was consistent with Dickinson et al finding where he showed that P. gingivalis was able to 
invade the oral epithelium and contaminated epithelial cells, while actinomycetemcomitans and 
F. nucleatum remained extracellularly (Dickinson B.C et al., 2011) . On the other hand, when 
they measured the transepithelial electrical resistance none of the bacterial species disrupted 
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barrier function (Dickinson B.C et al., 2011). Katz et al demonstrated that P. gingivalis is able to 
invade the deeper structures of connective tissues and decreasing the transepithelial resistance in 
MDCK cells (Katz J, Sambandam V, WU J.H, Michalek S.M, & Balkovetz D.F, 2000). Also, 
Groeger S et al demonstrated that due to the virulence factor gingipain, P. gingivalis W83 At an 
MOI of 104 showed a decrease in the TER after 2 h (Groeger S et al., 2010). 
Epigenetic events such as DNA methylation effect gene expression through selective 
activation or inactivation of genes. DNA methylation induce changes in immune mechanisms, 
cytokine profile, and thereby contribute to the pathogenesis of inflammatory diseases. 
Periodontitis is a multifactorial disease that engages many mechanisms, several papers have 
reported that DNA methylation is involved in regulating key genes in periodontal disease (Barros 
S.P & Offenbacher S, 2014; Gomez R.S et al., 2009; Larsson L et al., 2015). Zhang et all, 
showed higher level of DNA methylation at two CpG sites in the TNF-a promotor region TNF-
a, of gingival biopsy from periodontitis patient compared to the healthy patient. The mRNA 
expression of TNF-a increase after treatment with 5-aza (Zhang S et al., 2013). Two studies 
have been investigated the methylation level of interferon (INF- g). Zhang et all, (Zhang et al., 
2010) found an increase transcription level of interferon INF- g and lower DNA methylation in 
periodontitis patient compared to healthy patient. On the other hand, Viana et all, (Viana M.B et 
al., 2011) found no different in the methylation status of INF- g and IL10 between gingival 
biopsy of healthy and periodontitis patient. Other evidence report methylation level of IL8 
(Oliveira N.F et al., 2009), IL-10 (Larsson L et al., 2012), Toll like receptor 2 (TLR2) (de Faria 
Amormino S. A et al., 2013); De Oliveira N.F et al. (2011), E-cadherin and cyclooxygenase2 
(COX-2) (Loo W.T et al., 2010), prostaglandin endoperoxide synthase 2 (PTGS2) (Zhang S et 
al., 2010) and collagen α1(Ohi T et al., 2006) in periodontal disease. We found a statistically 
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significant increase in DNA methylation status of PKP2 gene in HGE infected with live P. 
gingivalis and decrease in mRNA expression. Heat-killed P. gingivalis have no effect on PKP2, 
which suggests that PKP2 protein is affected by P. gingivalis products, which are likely to be 
proteases. F. nucleatum decrease PKP2 mRNA expression but it did not increase the methylation 
of PKP2, which suggest that F. nucleatum affecting HGE through different mechanism than P. 
gingivalis. PKP2 is an important protein for desmosome assembly and epithelial cell integrity. 
PKP2 loss results in a loss of desmoplakin (DP) assembly competence and its failure to 
accumulate normally at borders (Bass-Zubek A.E et al., 2008). Recent study showed that loss of 
PKP2  lead to loss of desmoplakin (DP) which lead to promotes TGF-β1/p38 MAPK- dependent 
fibrotic gene expression in cardiomyocytes (Dubash A.D et al., 2016).  
In the present study, the CpG analyzed in the promotor region of PKP2 gene are situated 
close to important transcription site, like NF-kb, SP-1, FOXp3, P53 (Figure 2.11). NF-kb play a 
central role in inflammation through it is ability to induce the transcription of pro-inflammatory 
gene (Barnes P.J & Karin M, 1997). Sp-1 regulates the expression of a large number of genes 
involved in a variety of processes such as cell growth, apoptosis, differentiation and immune 
responses (Kadonaga J.T, Masiarz F.R, & Tjian R, 1987). These data suggest that PKP2 may 
play an important role in maintaining epithelial integrity and may play an important protective 
role in the pathogenesis of periodontal disease. 
For E-cadherin there was no decrease in the expression of E-cadherin after infection with 
different periodontal pathogen. We did not expected a decrease the expression as decrease E-
cadherin expression is characteristic of cancer (Han Y.W, 2014; Kowalski P.J, Rubin M.A, & 
Kleer C.G, 2003; Rubinstein et al., 2013). Our finding is consistent with Belibasakis work were 
he analysis the expression of gingival epithelial junction in response to subgingival biofilms (red 
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complex) and in his finding there was no decrease in the expression of E-cadherin (Belibasakis 
G.N, Kast J.I, Thurnheer T, Akdis C.A, & Bostanci N, 2015). There are only two study report 
decrease in E-cadherin expression in human gingival epithelial cells by P. gingivalis (Abe-
Yutori et al., 2016; Katz et al., 2000). In both study, they treat the epithelial cell with different 
strain of P. gingivalis for 48h and they observe the expression of E-cadherin with 
immunofluorescent staining. Furthermore, pretreatment of HGE with DNMT-1 inhibitors 
(RG108-EGCG) followed by P. gingivalis stimulation result in improve barrier function, since 
there was no change in the TER increase the mRNA expression of PKP2 and decrease the 
methylation level compared to P. gingivalis infection. Therefore, we could suggest that DNMT-1 
inhibitors can improve the epithelial barrier function. Recent study by Wan et all, reported that 
EGCG reduced bacterial translocation through the enhancement of the intestinal epithelial barrier 
function by inducing secretion of antimicrobial peptides. Also, they conclude that EGCG can be 
used to prevent intestinal disorders or bacterial infection in animals/humans (Wan M.L, Ling 
K.H, Wang M.F, & El-Nezami H, 2016). Both DNMT-1 inhibitors (RG108, EGCG) we used in 
this study are non-nuclease with no genotoxicity compared to 5-aza (Stresemann C et al., 2006). 
Unfortunately, there is limited research has been done using DNMT-1 inhibitors as treatments 
for periodontitis. These drugs are able to target epigenetic modification can be used to 
personalized treatment and preventive periodontal disease, the challenge with this approach is to 
specifically target the epigenetic marks which have a negative influence on the gene, leaving 
alone the beneficial one that help maintain health. 
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Figure 0.11 Human PKP2 GENE A) Genomic sequence of the PKP2 300 bp from promoter 
region. Sites for potential transcriptional factor binding are over and underlined. CpG potential 
methylation sites are in boldface. B) Schematic representation of the human PKP2 promoter. The 
circles are representative of the CpG dinucleotides evaluated and the binding sites for different 
transcription factors are indicated. 
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II.7 SUPPLEMENTARY  
 	
Figure 0.12 The adjusted mean of TER of human gingival epithelial (HGE) after pretreat the 
HGE with RG108 or EGCG.
	
Figure 0.13 Mean percentage of DNA hypermethylation for PKP2 after pretreated the HGE with 
RG108 or EGCG 
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Figure 0.14 mRNA Level of PKP2 and E-cadherin after pretreat the HGE with RG108 or EGCG 
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